Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to fall 34.58% to -34 cents per share on November 18

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q3'26

Est.

$-0.35

Q2'26

Beat

by $0.04

Q1'26

Missed

by $0.48

Q4'25

Missed

by $0.60

Q3'25

Missed

by $1.08

The last earnings report on August 14 showed earnings per share of -52 cents, beating the estimate of -56 cents. With 51.24K shares outstanding, the current market capitalization sits at 6.32M.

View a ticker or compare two or three

ACXP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days